4//SEC Filing
Hanlon Suzanne M. 4
Accession 0001192482-20-000091
CIK 0001621443other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:34 PM ET
Size
5.5 KB
Accession
0001192482-20-000091
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2020-01-30+60,000→ 60,000 totalExercise: $5.05Exp: 2030-01-30→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001631682
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:34 PM ET
- Size
- 5.5 KB